CDTX vs PLD · rev $1.3M vs P/E 27, rev $8.79B
Cidara Therapeutics Inc (CDTX) versus Prologis Inc (PLD) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported PLD revenue for 2025-12-31 was $8.79B. Net income was $3.33B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
CDTX currently screens at market cap $6.96B. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Not investment advice. Open the CDTX and PLD stock pages for the full models.
Not investment advice.